4-CHLORO-N-(PYRIDIN-2-YL)PYRIDIN-2-AMINE, 90.0%, 2g

2,6-Difluoro-4-methoxyphenol, 97%, 10g

2-(2-HYDROXYPHENYL)-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE-8-CARBOXYLIC ACID, 95.0%, 500mg

3-Isobutyl-1-methyl-1H-pyrazole-5-carboxylic acid, 95.0%, 10g

Colonna capillare per GC ROTI®Cap-1701 MS, 60 m, 0,25 mm, 0,50 µm, 1 Pezzo(i)

tetrahydro-3-thiopheneol, 95.0%, 1g

(S)-tert-Butyl 4-(tert-butyl)-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide, 98%, 5g

(2,3,5-Trifluorophenyl)acetic acid ethyl ester, 97.0%, 1g

(S,S)-(-)-Bis(alpha-methylbenzyl)amine Hydrochloride>98.0%(HPLC)(T)5g

trans-1,2-Diaminocyclohexane (Racemic), 98.0%, 250ml

6-(Aminomethyl)pyridin-2(1H)-one hydrobromide, 97%, 250mg

2-BENZYL-6-METHOXY-1,2,3,4-TETRAHYDROISOQUINOLINE, 95+%, 250mg

3-(4-Methylpyridin-3-yl)propan-1-ol, 95%, 100mg